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Decisions made by healthcare professionals on the prevention and 
management of ill health are at the core of an effective, efficient and 
trusted health system. Clinical practice guidelines (CPGs) can have a 
substantial influence on clinical decision-making, with consequences 
for health outcomes, patients’ access to care, health system costs and 
resource use.
The white paper on National Health Insurance (NHI) policy for 
South Africa (SA)[1] released in June 2017 suggests that detailed 
treatment guidelines, based on the best available clinical and cost-
effectiveness evidence, will be used to guide the delivery of health 
services under NHI. Under NHI, standard treatment guidelines 
(STGs) developed by the National Department of Health (NDoH) 
for primary, secondary, tertiary and quaternary levels of care will 
play an integral role in determining access to and quality of care, 
and additional treatment guidelines will be used or developed where 
gaps in the therapeutic areas covered by the STGs are identified. In 
addition, the NHI policy states that ‘efforts will be put into place 
to ensure that the general public is provided with the relevant 
information to support access and ensure empowerment regarding 
these guidelines’.[1]
However, no central, accessible database of CPGs developed in SA 
currently exists.[2] The CPG mapping project described in this article 
aimed to address this gap in knowledge of up-to-date guidelines, and 
to assist the NDoH by: (i) improving the current understanding of 
the CPG landscape in SA; and (ii) providing a starting point for a 
co-ordinated CPG review and development programme under NHI. 
The primary objective of this project was to identify and collate all 
publicly available CPGs and, where available, to provide the details of 
the developers/commissioners of such guidance.
For the purpose of this research, and the intended NHI-focused 
requirements of guideline production in SA, we defined CPGs 
in their broadest sense as documentation that advises on the 
clinical management (including screening, prevention, diagnosis, 
treatment, rehabilitation and palliation) of individuals in a particular 
setting for a particular disease area/condition. The use of a more 
restrictive definition of CPGs, for example the Institute of Medicine’s 
2011 definition that includes a requirement that CPG statements/
recommendations ‘are informed by a systematic review of evidence 
and an assessment of the benefits and harms of alternative care 
options’,[3] was not considered practical or appropriate, as the 
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Background. South Africa (SA) is in the process of implementing National Health Insurance (NHI), which will require co-ordination of 
health provision across sectors and levels of care. Clinical practice guidelines (CPGs) are tools for standardising and implementing care, and 
are intended to influence clinical decision-making with consequences for patient outcomes, health system costs and resource use. Under 
NHI, CPGs will be used to guide the provision of healthcare for South Africans. It is therefore important to explore the current landscape 
of CPG developers and development.
Objective. To identify and describe all CPGs available in the public domain produced by SA developers for the SA context.
Methods. We conducted a cross-sectional evaluation using a two-part search process: an iterative, electronic search of grey literature and 
relevant websites (161 websites searched), and a systematic search for peer-reviewed literature (PubMed) after publication year 2000. CPGs 
were identified, and data were extracted and categorised by two independent reviewers. Any discrepancies were referred to a third reviewer. 
Data extracted included a description of the developer, condition, and reporting of items associated with CPG quality.
Results. A search conducted in May 2017 identified 285 CPGs published after January 2000. Of those, 171 had been developed in the 
past 5 years. Developers included the national and provincial departments of health (DoH), professional societies and associations, ad 
hoc collaborations of clinicians, and the Council for Medical Schemes. Topics varied by developer; DoH CPGs focused on high-burden 
conditions (HIV/AIDS, tuberculosis and malaria), and other developers focused on non-communicable diseases. A conflict of interest 
statement was included in 23% of CPGs developed by societies or clinicians, compared with 4% of DoH CPGs.
Conclusion. Accessing CPGs was challenging and required extensive searching. SA has many contributors to CPG development from the 
public and private sectors and across disciplines, but there is no formal co-ordination or prioritisation of topics for CPG development. 
Different versions of the CPGs were identified and key quality items were poorly reported, potentially affecting the usability and credibility 
of those available. There was substantial variation in CPG comprehensiveness and methodological approach. Establishing a national CPG 
co-ordinating unit responsible for developing standards for CPG development along with clinical quality standards, and supporting high-
quality CPG development, is one essential step for moving forward with NHI.
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CPG landscape in SA is fragmented and 
not currently standardised, with limited 
technical skills available.[4] As a result, 
the CPGs included in the database vary 
considerably in terms of their development 
methods, quality and comprehensiveness.
Objective
To identify and describe all CPGs available 
in the public domain, produced by SA 
developers for the SA context.
Methods
We conducted a cross-sectional evaluation 
of publicly available CPGs through an 
iterative, electronic search of grey literature 
and relevant websites, as well as a systematic 
search for peer-reviewed literature.
Documentation relevant to the clinical 
management of individuals in SA (see full 
definition above) produced and published 
after 1 January 2000 in English was included 
in the CPG database. Only one version or 
presentation of any CPG was included, and 
non-clinical guidelines describing ethical, 
legal, organisational or infrastructure factors 
for healthcare were excluded. Continuing 
medical or professional education articles 
and academic textbooks were also excluded.
The electronic search of grey literature and 
relevant websites (national and provincial 
departments of health, professional soci-
eties, associations, universities) was conduc-
ted between 1 September 2016 and 15 Nov-
ember 2016, and repeated between 22 
and 25  May 2017. The list of society and 
association websites searched was informed 
by a separate Society, Association and 
Council Mapping Project,[5] as well as the list 
provided on the Health Professions Council 
of South Africa’s website (http://www.hpcsa.
co.za/Links). In the initial search, terms 
including ‘clinical guideline’, ‘treatment 
protocol’ and ‘recommendations’ were used 
to identify websites and grey-literature 
sources. This was followed by a pragmatic, 
within-site strategy to ensure that the search 
was comprehensive and that sources were 
fully examined.
The systematic search for peer-reviewed 
literature was conducted in PubMed and the 
South African Medical Journal (SAMJ) on 
18 October 2016, and updated by the first 
reviewer and repeated by the second reviewer 
on 12 May 2017. Articles published between 
1 January 2000 and 12 May 2017 were 
identi fied using search terms that included 
‘South Africa’ and variations of the following 
keywords: guideline; clinical management; 
treatment; protocol; recommend; algorithm; 
clinical practice guideline; decision support; 
managed care; diagnoses; preventive; public 
health; and health service. Two reviewers 
independently reviewed the abstracts against 
the prespecified inclusion and exclusion 
criteria, with any disagreement discussed 
and referred to a third reviewer if not 
resolved. The Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses 
(PRISMA) flow chart for the literature 
search is presented in Fig. 1.
Two independent reviewers extracted and 
categorised relevant information from the 
CPGs, with any disagreement discussed and 
referred to a third reviewer if not resolved. 
Information extracted included a description 
of the developer, condition and reporting of 
items associated with quality CPGs (e.g. 
declarations of conflicts of interest, funding 
sources, references or evidence base, and 
stakeholder involvement).
Results
In total, 285 CPGs published online after 
the year 2000 were retrieved. Fig. 2 provides 
an overview of the CPGs developed and 
published between January 2000 and May 
2017 in SA and the broad therapeutic areas 
they relate to. Most CPGs provide guidance 
on non-communicable diseases (NCDs) 
(46%, 130/285), maternal, neonatal and 
child health (MNCH) (21%, 59/285) and 
HIV/AIDS, tuberculosis (TB) or malaria 
(12%, 35/285). We found that 171/285 CPGs 
(60%) were developed after 1 January 2012. 
The apparent increase in CPG development 
since 2000 (Fig. 2) could in part be explained 
by the fact that only the latest version of any 
CPG was included in the database.
CPGs were categorised based on their 
scope as:
• Covering multiple conditions and popu-
lations. Short guidelines/algorithms cov-
ering multiple unrelated conditions or 
interventions.
• Detailed. Guidelines that include the fol-
lowing information regarding the condi-
tion or intervention: general information, 
symptoms and presentation of disease, 
diagnosis, and management/treatment 
recommendations.
• Position statement. Short (usually 1 - 3 
pages) recommendations or statements 
where the content is mainly based on the 
collective views of the organisation and 
not necessarily supported by analysis or 
synthesis of local evidence.
• Poster/algorithm. Algorithm or poster on 
the management of a particular condition 
or use of an intervention.
We identified five groups of CPG developers: 
(i) the NDoH; (ii) provincial departments 
of health; (iii) societies or associations; (iv) 
collaborations of clinicians and academics; 
and (v) the Council for Medical Schemes 
(CMS).
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Fig. 1. PRISMA flow diagram of clinical practice guidelines (May 2017).
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CPG developer types and categorisation are 
shown in Table 1. CPGs in each category 
vary in development methodology, length, 
target audience and scope (guidance on an 
individual intervention v. management of a 
condition).
Department of Health CPGs
Nine NDoH CPGs ‘covering multiple 
conditions and populations’ were identified: 
(i) three STGs for SA (primary care level, 
and hospital level for adults and children); 
(ii) Tertiary and Quaternary Level Essential 
Medicines Recommendations, 2016; (iii) 
Integrated Management of Childhood Illness 
(IMCI), 2014; (iv) Adult Primary Care guide, 
2016/2017; (v) Newborn Care Charts, 2014 
(these were developed by the Limpopo 
Initiative for Newborn Care, a joint initiative 
of the Department of Paediatrics and Child 
Health at the University of Limpopo and the 
Limpopo Department of Health, but have 
been categorised as an NDoH guideline 
owing to their national implementation 
and use); (vi) Guidelines for Neonatal Care, 
2008; and (vii) the STG for common mental 
health conditions. Outdated versions (when 
newer versions of the CPGs are available) of 
the STGs, the IMCI and the Adult Primary 
Care guide (previously named Primary 
Care 101) were found on multiple websites, 
including those of the NDoH, universities, 
provincial DoHs and professional societies 
and associations.
Most of the ‘detailed’ NDoH guidelines 
(n=45) were for HIV/AIDS, TB or mala-
ria (28%, 15/45), followed by CPGs for 
MNCH (20%, 9/45), NCDs (20%, 9/45) 
and communicable diseases and infections 
(19%, 8/45). Some of the NDoH CPGs were 
adaptations of World Health Organi zation 
(WHO) guidelines, and many were developed 
in collaboration with, or with financial 
or technical support from, international 
development aid agencies such as the United 
Nations Children’s Fund (UNICEF), United 
States Agency for International Development 
(USAID), United Nations Population 
Fund (UNFPA) and Joint United Nations 
Programme on HIV/AIDS (UNAIDS).
Only three of the ‘detailed’ CPGs by 
provincial DoHs were produced in the past 
5 years. Two of these were developed by 
the KwaZulu-Natal DoH for preventing 
and managing malnutrition, and one by 
the Western Cape DoH on antimicrobial 
management. The KwaZulu-Natal DoH 
also produced protocols for management of 
mental health conditions, and two paediatric 
CPGs ‘covering multiple conditions and 
populations’ in 2007.
Society or association CPGs
A total of 156 CPGs developed by 63 
societies or associations were identified, with 
the majority of organisations (54%, 34/63) 
producing or contributing to more than one 
CPG. Some of the CPGs were adaptations 
of guidelines developed by professional 
societies outside SA.
The majority of the CPGs were ‘detailed’ 
(67%, 104/156) and were mostly produced 
after 1 January 2012 (62%, 96/156). Sixty 
percent (94/156) of the CPGs advised on the 
management of NCDs, with many referring 
to musculoskeletal (14/94), cardiovascular 
(13/94) and gastrointestinal (12/94) condi-
tions.
None of the position statements identi-
fied (n=41) were published in a peer-
reviewed journal, and they were mainly 
developed by five societies: the South African 
Spine Society (n=12), the South African 
Vitreoretinal Society (n=6), the South 
African Gastroenterology Society (n=4), 
the South African Society of Cardiovascular 
Intervention (n=4) and the South African 
Society of Obstetricians and Gynaecologists 
(n=4).
Ten poster/algorithm guidelines were 
included in the CPG database, of which nine 
were produced by the Resuscitation Council 
of South Africa.
CPGs produced by clinicians  
and academics
Thirty-seven CPGs containing no formal 
statement linking their development to the 
DoH or a specific society or association were 
included as clinician/academic-produced 
CPGs. The majority of the CPGs were for 
MNCH (40%, 15/37), followed by NCDs 
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Fig. 2. CPGs produced in SA between January 2000 and May 2017 by broad therapeutic area (N=285). 
(CPGs = clinical practice guidelines; SA = South Africa; TB = tuberculosis; MNCH = maternal, 
neonatal, and child health; NCD = non-communicable disease. *One CPG on the use of blood products 
in SA has been included under the ‘Trauma and emergency’ field; however, this document includes 
guidance covering more than one broad therapeutic area for both adults and children. †The ‘Multiple 
(adults)’ field includes four documents that consist of a package of adult-focused CPGs covering more 
than one broad therapeutic area. Paediatric CPGs covering more than one broad therapeutic area are 
included under the MNCH field.)
Table 1. Overview of clinical practice guidelines in South Africa by developer type
National 
Department of 
Health, n
Provincial 
department of 
health, n
Society/
association, n
Clinicians/
academics, n
Council for 
Medical 
Schemes, n Total, N
Multiple conditions and populations 9 3 1 0 1 14
Detailed 45 10 104 37 14 210
Position statement 2 1 41 0 0 44
Poster/algorithm 3 4 10 0 0 17
Total 59 18 156 37 15 285
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(32%, 12/37), other communicable diseases and infections (14%, 
5/37) and HIV/AIDS, TB and malaria (8%, 3/37).
Most (33/37) of the CPGs were published in the SAMJ, with the 
rest available on journal and university websites: African Journals 
Online (AJOL) (n=1), the Journal of Endocrinology, Metabolism and 
Diabetes of South Africa (JEMDSA) (n=1), the University of KwaZulu-
Natal (n=1) and the University of Cape Town (n=1).
Council for Medical Schemes CPGs
Fifteen CPGs developed by the CMS were identified. These consist 
of one CPG ‘covering multiple conditions and populations’, which 
contains the algorithms specifying the minimum standards required 
(under Prescribed Minimum Benefits (PMB)) in the management 
of the 25 chronic conditions on the Chronic Diseases List, and 14 
‘detailed’ Diagnosis Treatment Pair CPGs published on the CMS 
website as a result of the PMB Definition Project.[6] The Diagnosis 
Treatment Pair CPGs all relate to cancer, cardiovascular disease and 
organ transplants.
Key quality criteria of included CPGs
Sixteen percent (47/285) of CPGs contained a statement regarding 
the authors’ conflicts of interest, and 23% (65/285) explicitly declared 
the funding source. The methods for stakeholder consultation as part 
of the CPG development process were described in 26% (75/285) of 
CPGs, and 71% (203/285) included references. A brief summary of 
the findings by developer type is presented in Table 2.
Seventeen of the 59 NDoH CPGs (29%) stated the involvement of 
international development partners (e.g. WHO, UNICEF, USAID) 
in the CPG development process. These CPGs had a strong focus 
on MNCH (n=8) and the management of HIV/AIDS, TB and 
malaria (n=6). Pharmaceutical industry involvement was declared or 
assumed (based on pharmaceutical industry advertisements directly 
within the CPG) in the development of 54 CPGs, of which two-thirds 
(36/54) were focused on NCDs.
Discussion
CPGs developed in SA vary considerably in terms of their topics, 
scope, development methods, funding streams and accessibility. 
This variability is not surprising considering the number and 
diversity of CPG developers, and the lack of formal co-ordination or 
standardisation between them with regard to CPG topic selection and 
prioritisation, development methodology and reporting principles.
The individual topic selection/prioritisation process followed by 
the developers was generally not reported, and therapeutic topics 
vary considerably. The majority of DoH CPGs were focused on 
high-burden conditions such as HIV/AIDS, TB and malaria, while 
CPGs from other developers were more likely to provide guidance 
on NCDs. One possible explanation for this variation in CPG topics 
is the difference in the type of conditions treated by public and 
private healthcare providers, and as a result the types of CPGs they 
need or are likely to access. The effect of the aims and objectives of 
funding organisations (e.g. pharmaceutical industry, international 
development partners) on CPG topic selection was not considered 
as part of this mapping project, but may warrant future research 
to ensure that CPG topics are prioritised and selected based on the 
needs of the population and the healthcare community.
CPGs identified in the public domain were often out of date (with 
more up-to-date versions available elsewhere) and key quality items 
we extracted were poorly reported, potentially impacting on the 
usability and credibility of those available.
Accessing CPGs was challenging, as no central database of CPGs 
currently exists. CPGs can be submitted to the SAMJ for publication, 
but no formal ‘clinical guidelines’ were published in the period 
between the introduction of the AGREE II assessment to the SAMJ 
critical appraisal process for clinical guidelines in 2014[7] and May 
2017. The systematic search for CPGs in the SAMJ retrieved 87 
Continuing Medical Education (CME) articles published between 
2014 and May 2017 that contained the features of a CPG. However, 
these articles were not subject to a peer review process prior to 
publication[8] and were not included in the CPG database. Some 
societies, associations, departmental organisations and universities 
publish CPGs on their websites, but in many cases the CPGs were out 
of date. The Ideal Clinic programme website consistently contained 
up-to-date versions of most of the core DoH guidelines (https://
www.idealclinic.org.za). The Ideal Clinic programme is an NDoH 
initiative, started in 2013, with a strong focus on the use of guidelines 
to support its aim of ‘systematically improving the quality of care 
provided in Primary Health Care facilities’.[9]
Strengths and limitations of the literature search
A systematic approach to identifying CPGs produced in SA and 
extracting the relevant data was followed. Detailed inclusion and 
exclusion criteria were established, based on a clear scope for the 
literature search. Dual review and data extraction of CPGs, as well 
Table 2. Summary of findings: Items associated with good-quality CPGs
National 
Department of 
Health (n=59)
Provincial 
department of 
health (n=18)
Societies / 
associations 
(n=156)
Clinicians and 
academics 
(n=37)
Council 
for Medical 
Schemes (n=15)
Funding statement Funding source not stated* (81%) 
or unclear† (3%)
Funding source 
not stated* 
(73%) or 
unclear† (2%)
22% declared 
pharmaceutical 
industry 
involvement 
Funding not 
stated* (59%) or 
unclear† (5%)
32% declared 
pharmaceutical 
industry 
involvement
Not stated 
(100%)
n=1 stated 
pharmaceutical 
industry 
involvement
None stated 
pharmaceutical 
industry 
involvement
Conflict of interest statements, % 0 17 21 30 0
References available, % 54 28 74 100 93
Description of stakeholder consultation process, % 32 28 26 30 0
CPG = clinical practice guideline.
*A CPG funding source was categorised as ‘not stated’ if there was no explicit statement in that regard. There were cases where the involvement of international partners or the pharmaceutical 
industry in CPG development was stated, but the nature of their involvement (human resources or financial) was not declared.
†A CPG funding source was categorised as ‘unclear’ if the funding source was not stated, but a commercial advertisement or logo of a pharmaceutical company appeared in the CPG.
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as a search of grey literature, were conducted to minimise potential 
selection bias.
Despite the comprehensive search, given the difficulty with 
identifying CPGs, it is probable that CPGs are missing. Non-English-
language CPGs were excluded, so guidance produced in any of the 
other official languages in SA will not have been retrieved, and 
guidelines that were not dated may potentially have been missed.
Key criteria regarding funding and conflicts of interest were 
extracted, but a robust quality assessment of CPGs was not conducted. 
Two prior studies have evaluated the quality of a sample of CPGs 
in SA using the AGREE II checklist, and consistently found the 
reporting on several aspects of the methods for CPG development to 
be of low to moderate quality.[2,10] Further quality appraisal on the full 
set of CPGs may not provide additional insight.
Conclusions
SA has a diverse CPG-developing community, but the challenges 
faced by clinicians in accessing up-to-date CPGs and the lack of 
co-ordination between developers may limit the impact of CPG 
developers’ efforts to guide and improve the delivery of high-quality 
patient care.
Developing and maintaining an accessible, up-to-date CPG 
repository is a practical and useful first step towards improving the 
availability of CPGs in SA. The 285 CPGs identified through this 
mapping project provide a starting point for such a repository. In 
addition to a point of access for clinicians, this CPG database can 
also be used to inform the planning and determination of service 
benefits under NHI, and provide information for a clinical guidance 
gap analysis to identify topic areas where future CPG development 
will be most beneficial. Useful lessons can be learnt from information 
technology organisations such as the Open Medicines Project and 
Essential Medical Guidance (EMGuidance), which are already working 
collaboratively, developing and maintaining smartphone applications 
that provide access to the most up-to-date versions of NDoH 
CPGs (STGs, Tertiary and Quaternary Level Essential Medicines 
Recommendations, TB and HIV)[11] and some CPGs produced by 
other SA developers.[12]
Stakeholder involvement is a crucial component that needs to 
be incorporated in all stages of the CPG development process. The 
South African Medical Association (SAMA) is currently ‘engaging 
its medical practitioner members to contribute substantively to the 
develop ment of guidelines, sharing their experience and expertise 
in the process’. [13] This could potentially improve the credibility and 
acceptability of CPGs by healthcare professionals across both the 
private and public sectors, and ultimately result in meaningful changes 
in clinical practice. Clinical quality standards are useful tools that can 
be used to further aid and enhance CPG implementation, and evaluate 
their clinical impact under NHI. Patient involvement in the CPG 
development process should also be considered, to ensure that patients 
are involved and empowered in decisions affecting their health.
In addition, the findings from this CPG mapping project and the 
South African Guidelines Excellence (SAGE) project[4] demonstrate 
the need for a national, co-ordinating CPG unit that will enable a 
standardised, co-ordinated and evidence-based approach to CPG 
development. A national co-ordinating body will be essential if CPGs 
are to inform patient care under NHI, with a likely impact on quality 
of care. Ideally it will be responsible for developing and upholding 
key components of CPG production, which includes robust processes 
for topic selection and prioritisation, development, publication/
implementation and review.
A full list of the CPGs identified is available on the PRICELESS SA 
website (www.priceless.ac.za).
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